Evidence map›Paper›PMID 30988795›Full record

ArticleExperimental and therapeutic medicine2019

Honokiol induces apoptotic cell death by oxidative burst and mitochondrial hyperpolarization of bladder cancer cells.

Chi-Hao Hsiao, Chih-Jung Yao, Gi-Ming Lai, Liang-Ming Lee, Jacqueline Whang-Peng, Ping-Hsiao Shih

Open access · diamondAbstract read
In one paragraph

Article in Experimental and therapeutic medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 21 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Honokiol Suppression of Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Gastric Cancer Cell Biological Activity and Its Mechanism.Medical science monitor : international medical journal of experimental and clinical research · 2020
    Article
  9. Article
  10. Review
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Chi-Hao HsiaoDepartment of Urology, Wan Fang Hospital, Taipei 11696, Taiwan R.O.C.
Chih-Jung YaoCancer Center, Wan Fang Hospital, Taipei 11696, Taiwan R.O.C.
Gi-Ming LaiCancer Center, Wan Fang Hospital, Taipei 11696, Taiwan R.O.C.
Liang-Ming LeeDepartment of Urology, Wan Fang Hospital, Taipei 11696, Taiwan R.O.C.
Jacqueline Whang-PengCancer Center, Wan Fang Hospital, Taipei 11696, Taiwan R.O.C.
Ping-Hsiao ShihCenter for Cell Therapy, Department of Medical Research, China Medical University Hospital, Taichung 40447, Taiwan R.O.C.
Wan Fang Hospital · TWChina Medical University · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bladder cancer is one of the most common types of malignant tumor worldwide. Current treatments, including chemo-/radiotherapy, only have limited efficacy on bladder cancer progression. Honokiol is an active component of

Indexed as

apoptosisbladder cancerflow cytometryhonokiolmagnolia officinalismitochondrial membrane hyperpolarizationoxidative stress

Identifiers

PMID30988795
PMCPMC6447899
OpenAlexW2922627960

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.